When a risk factor becomes a disease
A risk factor is a measurable characteristic, such as blood pressure, blood sugar, cholesterol, or bone density, that raises the statistical likelihood of a future illness without itself being that illness. When a risk factor is renamed as a condition in its own right, such as prehypertension, prediabetes, or osteopenia, healthy people who feel entirely well can suddenly be reclassified as patients with a diagnosis. This page examines that shift and, along the way, distinguishes two very different senses of the phrase pre-existing disease: the clinical idea of a not-yet-disease and the insurance idea of a condition that predates a policy. They sound alike and are constantly confused, but they mean different things.
Pre-existing disease: the insurance meaning
In health insurance, a pre-existing disease is a defined term of contract, not a medical judgment. It generally means any illness, injury, or condition that a person had, was diagnosed with, or received treatment or advice for within a specified window before a policy started. Insurers use the definition to decide what a policy will and will not cover, often applying a waiting period before certain conditions become claimable.
What counts varies by insurer and jurisdiction, but a pre-existing disease list commonly includes established chronic and serious conditions such as diabetes, cardiovascular disease, cerebrovascular disease, chronic kidney disease, cancer, and other long-standing illnesses; it usually excludes short-lived infectious illnesses. The key feature is that this meaning is administrative. It is about timing and paperwork, not about whether a borderline number should be treated as sickness. Readers researching what their policy covers should check their own contract and the applicable regulations, because this reference cannot give insurance or legal advice.
Pre-disease: when a number becomes a diagnosis
The other, quite separate meaning is the clinical one that this site studies: the creation of pre-diseases, in which a risk factor is given a diagnostic name that makes a healthy person sound already ill. The general form is always the same. A continuous measurement runs smoothly from low to high risk, an expert group draws a threshold across it, and everyone above the line, including many people at only slightly elevated risk, is placed in a newly named category. Because risk rises gradually and the cut-off is a decision rather than a natural boundary, small changes in where the line is drawn can move very large numbers of people into or out of the diagnosed group.
Prehypertension and the lowering of blood-pressure lines
Blood pressure illustrates this vividly. In 2003, a United States expert panel introduced the category of prehypertension for readings that were above the traditional normal range but below the line for hypertension, describing people in that band as being at increased future risk. In 2017, American cardiology guidelines went further and reclassified those ranges, so that readings once called normal-high were relabeled as elevated blood pressure or stage 1 hypertension. Each redefinition was defended on the grounds of preventing later cardiovascular and cerebrovascular disease, and each also, at a stroke, converted millions of previously healthy people into candidates for monitoring, lifestyle intervention, or medication.
Prediabetes and borderline blood sugar
Prediabetes is the diabetes equivalent: blood-sugar measurements above normal but below the diabetes threshold, captured through impaired fasting glucose or a glycated hemoglobin in a defined intermediate band. The label is promoted as an early warning that allows people to change course before chronic disease develops. Critics note that only a fraction of those labeled will ever progress to diabetes, that the intermediate cut-offs have been contested, and that different expert bodies have drawn the lines in different places, so the same person can be prediabetic under one definition and normal under another.
Osteopenia and bone density
Osteopenia shows how a threshold can be almost an afterthought. When a World Health Organization study group set bone-density categories in the 1990s, it defined osteoporosis and, above it, a milder band called osteopenia, based on how far a measurement sits from that of a healthy young adult. Osteopenia describes lower-than-peak bone density that is common with age and, for most people who have it, carries only modestly increased risk. Yet the diagnostic name can prompt anxiety and treatment decisions out of proportion to that risk.
Why threshold-lowering turns healthy people into patients
The mechanism connecting these examples is not fraud; it is the ordinary logic of prevention meeting the arithmetic of thresholds. Lowering a cut-off is easy to justify one case at a time, because at the margin there is always some additional risk to be found and some plausible benefit to earlier action. The cumulative effect is what draws scrutiny. A single downward adjustment of a line can reclassify a substantial share of the adult population overnight, and expert panels setting these thresholds have at times included members with financial ties to companies that make the relevant treatments, which is one reason critics argue for independent, transparent threshold-setting.
The parallel items below summarize the shift from measurement to diagnosis. In each, the underlying factor is real and worth understanding; the debated step is turning the factor itself into a disease.
| Pre-disease label | Underlying risk factor | Disease it points toward |
|---|---|---|
| Prehypertension / elevated blood pressure | Blood pressure above the old normal band | Cardiovascular and cerebrovascular disease |
| Prediabetes | Blood sugar between normal and diabetic | Type 2 diabetes and its complications |
| Osteopenia | Bone density below the young-adult peak | Osteoporosis and fractures |
| Borderline high cholesterol | Lipid levels above target | Heart disease |
The genuine trade-offs
Labeling risk factors as conditions is not simply a mistake, and a fair account has to hold both sides. Early identification can genuinely help. For some people, learning that a number is drifting upward is the prompt that leads to changes in diet, activity, or, where appropriate, medication that prevents a serious future illness. A named category can also focus attention and research on prevention rather than waiting for damage to occur.
The costs fall on the many people who are relabeled but would never have gone on to develop the disease. They may carry the worry of a diagnosis, face higher insurance scrutiny, undergo further tests, and take medication whose benefits at low levels of risk are small while its side effects and costs are not. The balanced view, argued by researchers who study overdiagnosis, is that risk factors deserve honest, individualized discussion of absolute benefit and harm, not automatic conversion into disease. Whether the pre-disease frame helps a particular person depends on their overall risk, and that is a conversation for them and a clinician. This page explains the debate and offers no diagnosis or treatment advice.